MDT Large Cap Growth SMA Model Portfolio Holdings -- December 31, 2020

Total Page：16

File Type：pdf, Size：1020Kb

MDT Large Cap Growth SMA Model Portfolio Holdings -- December 31, 2020 Sector Holding Name Communication Services Activision Blizzard, Inc. Alphabet Inc.* Cable One, Inc. Charter Communications Inc Facebook, Inc.* MSG Networks Inc. Netflix, Inc. TripAdvisor, Inc. Consumer Discretionary Amazon.com, Inc.* AutoZone, Inc. Dollar General Corporation Domino's Pizza, Inc. eBay Inc. Etsy, Inc. Lowe's Companies, Inc. McDonald's Corporation Nike, Inc. - CL B O'Reilly Automotive, Inc. Tesla, Inc. The Home Depot, Inc. Yum! Brands, Inc. Church & Dwight Co., Inc. Consumer Staples Costco Wholesale Corporation Flowers Foods, Inc. Monster Beverage Corporation PepsiCo, Inc. The Clorox Company Financials Arch Capital Group Ltd. MarketAxess Holdings Inc. MSCI Inc. S&P Global Inc. The Travelers Companies, Inc. Health Care Abbott Laboratories Abbvie, Inc. Amgen Inc. Anthem, Inc. Avantor Inc CIGNA Corporation Eli Lilly and Company Hologic, Inc. Horizon Therapeutics PLC Humana Inc. IDEXX Laboratories, Inc. IQVIA Holdings Inc. Merck & Co., Inc. Mettler-Toledo International Molina Healthcare, Inc. Sage Therapeutics, Inc. Seagen, Inc. UnitedHealth Group Incorporated Veeva Systems Inc. Vertex Pharmaceuticals Incorporated Waters Corporation Zoetis Inc. Industrials Acuity Brands, Inc. Carrier Global Corporation Flowserve Corporation Generac Holdings Inc. Hubbell, Inc. IAA, Inc. KAR Auction Services, Inc. Lockheed Martin Corporation R.R. Donnelley & Sons Company Verisk Analytics, Inc. Information Technology Adobe Systems Incorporated* Apple Inc.* Applied Materials, Inc. Arista Networks, Inc. Autodesk, Inc. Broadcom Limited Cadence Design Systems, Inc.* Crowdstrike Holdings, Inc. EPAM Systems, Inc. Fleet Financial Group Inc Fortinet, Inc. GoDaddy Inc. HubSpot, Inc. Intuit Inc. Keysight Technologies, Inc. Mastercard Incorporated Microsoft Corporation* NVIDIA Corporation* Okta, Inc. Oracle Corporation Paychex, Inc. Paylocity Holding Corporation PayPal Holdings, Inc.* Qualcomm Inc.* salesforce.com, inc. ServiceNow, Inc. Square, Inc. Synopsys, Inc. Teradyne Inc Texas Instruments Incorporated The Trade Desk, Inc. VeriSign, Inc Workday, Inc. Zoom Video Communications, Inc. Materials The Sherwin-Williams Company Real Estate Coresite Realty Corp. SBA Communications Corporation *Top 10 holdings are based on the model portfolio Supplemental to the full GIPS report. 39332 (1/21) MDT Advisers, a Federated Advisory Company.

Copy Link

Recommended publications

Prostate Cancer in Focus
PROSTATE CANCER IN FOCUS Current Developments in the Management of Prostate Cancer Section Editor: Andrew J. Armstrong, MD Prostate Cancer Prostate PSMA-Targeted Therapy in Prostate Cancer Scott T. Tagawa, MD, MS Professor of Medicine and Urology Weill Cornell Medicine New York, New York H&O What is prostate-specific membrane agent such as a monoclonal antibody might be able to antigen (PSMA), and what makes it a good target target a tumor without binding to other PSMA-positive for the treatment of prostate cancer? sites owing to its large size and physical inability to reach luminal sites of expression that are separated from the ST PSMA is a cell surface antigen that is expressed to vasculature by tight junctions. a limited degree on certain normal cells in the body but generally is highly overexpressed in the setting of prostate H&O How is PSMA positivity established? cancer. Normal cells that express PSMA are located in the prostate, salivary, and lacrimal glands; the proximal part ST Imaging and biopsy are the main ways to establish of the small intestine; the proximal renal tubules; and PSMA positivity. Multiple imaging modalities are avail- some ganglia. In the setting of prostate cancer, PSMA able worldwide. The agent indium In 111 capromab expression generally increases along with the cancer grade, pendetide (ProstaScint) has been approved for years in and it also increases following hormonal therapy. In addi- the United States, and the US Food and Drug Adminis- tion, PSMA expression tends to be higher in metastatic tration (FDA) approved the use of gallium Ga 68 PSMA- sites than in primary tumors.
[Show full text]
Paypal's Security
PayPal’s Security Key PayPal is a great service for enabling both businesses and consumers to buy and sell goods and services online without exposing private financial information to the other parties in a transaction. As a consumer, you can safely purchase goods and services online without exposing your credit or debit card information to be recorded and possibly misused. As a business, you can be paid for your goods or services using the Web or email without the need of storing your customer’s private financial information. A big concern with PayPal is that anyone who knows the password of your PayPal account can access the financial services that you have authorized to be used with PayPal. For consumers, this means that unauthorized purchases or cash transfer may be performed from your credit cards and bank accounts. As a business, unauthorized PayPal access can be a source of fraudulent purchases. Password security is always the responsibility of the PayPal account holder; but now PayPal has a service to make the disclosure of your PayPal password an almost insignificant threat. In February 2007, PayPal introduced an optional security key system for users to access their PayPal accounts. The security key does not replace your PayPal password; instead, it adds an extra layer of security by requiring an additional security code be entered with your password when you log into your PayPal account. What makes this security code so different from a password is that it randomly generated by a small, electronic device called a security token, which is a key fob that easily fits in the palm of your hand.
[Show full text]
MM .1.20 Clking
CL King Market Maker List AAXN Axon Enterprise, Inc. CROX Crocs, Inc. HELE Helen of Troy Limited MPAA Motorcar Parts of America, Inc. SBAC SBA Communications Corporation ADBE Adobe Inc. CSCO Cisco Systems, Inc. HIBB Hibbett Sports, Inc. MRVL Marvell Technology Group Ltd. SBUX Starbucks Corporation ADSK Autodesk, Inc. CSOD Cornerstone OnDemand, Inc. HLIT Harmonic Inc. MSFT Microsoft Corporation SCVL Shoe Carnival, Inc. ADTN ADTRAN, Inc. CTAS Cintas Corporation HSIC Henry Schein, Inc. MU Micron Technology, Inc. SGMS Scientific Games Corp AGNC AGNC Investment Corp. CTSH Cognizant Technology Solutions Corporation HSII Heidrick & Struggles International, Inc. NDLS Noodles & Company SHOO Steven Madden, Ltd. AIMC Altra Industrial Motion Corp. CVLT Commvault Systems, Inc. HSKA Heska Corporation NEOG Neogen Corporation SMPL The Simply Good Foods Company ALGT Allegiant Travel Company DAKT Daktronics, Inc. HSON Hudson Global, Inc. NLOK NortonLifeLock Inc. SMRT Stein Mart, Inc. AMZN Amazon.com, Inc. DECK Deckers Outdoor Corporation IART Integra LifeSciences Holdings Corporation NTUS Natus Medical Incorporated SMSI Smith Micro Software, Inc. ANDE The Andersons, Inc. DENN Denny's Corporation ICON Iconix Brand Group, Inc. ON ON Semiconductor Corporation SNBR Sleep Number Corporation ANGO AngioDynamics, Inc. DIOD Diodes Incorporated IDXX IDEXX Laboratories, Inc. OSUR OraSure Technologies, Inc. SQBG Sequential Brands Group, Inc. ANSS ANSYS, Inc. DISCA Discovery, Inc. ILMN Illumina, Inc. Holdings PACB Pacific Biosciences of California, Inc. SRDX Surmodics, Inc. AOBC American Outdoor Brands Corporation DISH DISH Network Corporation IMBI iMedia Brands, Inc. PATK Patrick Industries, Inc. STAF Staffing 360 Solutions, Inc. AOSL Alpha and Omega Semiconductor Limited DLTR Dollar Tree, Inc. IOSP Innospec Inc. PDCO Patterson Companies, Inc.
[Show full text]
Zoom Go Boom!
Security Now! Transcript of Episode #761 Page 1 of 21 Transcript of Episode #761 Zoom Go Boom! Description: This week starts off with a bunch of web browser news including Firefox zero-days, Safari's recent scrape, more coronavirus-related feature rollbacks, the status of TLS v1.0 and 1.1, and some interesting developments on the Edge front. We revisit the lingering STIR and SHAKEN telco protocol mess, then look at a new DNS-filtering add-on service from Cloudflare and at the growing influence of an Internet group hoping to tighten up the mess with BGP. After a quick update on my SpinRite project, we take a look at what's been going on with the security of Zoom, the suddenly chosen tool for hosting Internet virtual classrooms and meetings of all kinds. High quality (64 kbps) mp3 audio file URL: http://media.GRC.com/sn/SN-761.mp3 Quarter size (16 kbps) mp3 audio file URL: http://media.GRC.com/sn/sn-761-lq.mp3 SHOW TEASE: It's time for Security Now!. Steve Gibson is here. Lots to talk about including a Mozilla Firefox zero-day. It's been fixed, but just barely. A problem with Safari. BGP gets some MANRS. And what's wrong with Zoom, and a pretty good alternative. It's all coming up next on Security Now!. Leo Laporte: This is Security Now! with Steve Gibson, Episode 761, recorded Tuesday, April 7th, 2020: Zoom Go Boom! It's time for Security Now!, the show where we cover your security and privacy and safety and quarantine online.
[Show full text]
Refreshing the Biologic Pipeline 2020
news feature Credit: Science Lab / Alamy Stock Photo Refreshing the biologic pipeline 2020 In the absence of face-to-face meetings, FDA and industry implemented regulatory workarounds to maintain drug and biologics approvals. These could be here to stay. John Hodgson OVID-19 might have been expected since 1996) — a small miracle in itself “COVID-19 confronted us with the need to severely impair drug approvals (Fig. 1 and Table 1). to better triage sponsors’ questions,” says Cin 2020. In the event, however, To the usual crop of rare disease and Peter Marks, the director of the Center for industry and regulators delivered a small genetic-niche cancer treatments, 2020 Biologics Evaluation and Research (CBER) miracle. They found workarounds and also added a chimeric antigen receptor at the FDA. “That was perhaps the single surrogate methods of engagement. Starting (CAR)-T cell therapy with a cleaner biggest takeaway from the pandemic related in January 2020, when the outbreak veered manufacturing process and the first to product applications.” Marks says that it westward, the number of face-to face approved blockbuster indication for a became very apparent with some COVID- meetings declined rapidly; by March, small-interfering RNA (siRNA) — the 19-related files that resolving a single they were replaced by Webex and Teams. European Medicines Agency’s (EMA) issue can help a sponsor enormously and (Secure Zoom meeting are to be added registration of the RNA interference accelerate the development cycle. Before this year.) And remarkably, by 31 December, (RNAi) therapy Leqvio (inclisiran) for COVID-19, it was conceivable that a small the US Food and Drug Administration cardiovascular disease.
[Show full text]
Cornerstone 8.3 Getting Started Guide 3 Introduction
IDEXX Cornerstone* Getting Started Guide 8.3 Proprietary Rights Notice Information in this document is subject to change without notice. Companies, names and data used in examples are fictitious unless otherwise noted. No part of this document may be reproduced or transmitted in any form or by any means, electronic, mechanical or otherwise, for any purpose, without the express written permission of IDEXX Laboratories. IDEXX Laboratories may have patents or pending patent applications, trademarks, copyrights or other intellectual or industrial property rights covering this document or subject matter in this document. The furnishing of this document does not give a license to these property rights except as expressly provided in any written license agreement from IDEXX Laboratories. © 2014 IDEXX Laboratories, Inc. All rights reserved. • 06-28486-05 *Cornerstone, IDEXX SmartOrder, IDEXX SmartService, IDEXX Monitor, IDEXX VetLab, IDEXX VetVault, Image Coach, I-Vision Mobile, LaserCyte, Patient Clipboard, Pet Health Network, SmartLink, VetConnect and VetTest are trademarks or registered trademarks of IDEXX Laboratories, Inc. or its affiliates in the United States and/or other countries. DICOM is the registered trademark of the National Electrical Manufacturers Association for its standards publications relating to digital communication of medical information. Microsoft, Hotmail, Internet Explorer, Outlook, Windows, Windows Server and Windows Vista are trademarks or registered trademarks of Microsoft Corporation in the United States and/or other countries. Accelerated Payment Technologies and XCharge are trademarks or registered trademarks of Accelerated Payment Technologies, Inc. Topaz, ClipGem, SigLite and SignatureGem are trademarks of Topaz Systems, Inc. in the U.S. and/or other countries. AMD Athlon, Opteron and Sempron are trademarks of Advanced Micro Devices, Inc.
[Show full text]
VIRTUS ZEVENBERGEN INNOVATIVE GROWTH STOCK FUND SCHEDULE of INVESTMENTS (Unaudited) MARCH 31, 2021
VIRTUS ZEVENBERGEN INNOVATIVE GROWTH STOCK FUND SCHEDULE OF INVESTMENTS (Unaudited) MARCH 31, 2021 ($ reported in thousands) Shares Value Shares Value Footnote Legend: (1) Non-income producing. COMMON STOCKS—99.0% Industrials—3.9% Communication Services—9.3% Desktop Metal, Inc. (1) Country Weightings† Coursera, Inc.(1) 7,100 $ 320 Class A 359,800 $ 5,361 (1) Uber Technologies, United States 87% Netflix, Inc. 84,500 44,080 (1) Snap, Inc. Class A(1) 586,650 30,676 Inc. 897,900 48,944 Canada 7 Zillow Group, Inc. 54,305 Brazil 5 Class C(1) 434,335 56,307 Israel 1 Information Technology—43.9% Total 100% 131,383 (1) Coupa Software, Inc. 78,450 19,964 † (1) % of total investments as of March 31, 2021. Consumer Discretionary—25.3% fuboTV, Inc. 315,350 6,976 (1) NVIDIA Corp. 107,000 57,131 Airbnb, Inc. Class A 91,100 17,121 (1) Amazon.com, Inc.(1) 15,200 47,030 Okta, Inc. 235,575 51,928 (1) Paylocity Holding Chegg, Inc. 322,325 27,610 (1) (1) Corp. 110,750 19,916 Chewy, Inc. Class A 340,400 28,835 (1) Fiverr International PayPal Holdings, Inc. 198,850 48,289 Ltd.(1) 27,650 6,005 QUALCOMM, Inc. 204,050 27,055 RingCentral, Inc. Lululemon Athletica, (1) (1) Class A 129,800 38,665 Inc. 41,690 12,787 (1) (1) ServiceNow, Inc. 78,325 39,171 MercadoLibre, Inc. 48,225 70,994 (1) Peloton Interactive, Inc. Shopify, Inc. Class A 78,200 86,528 (1) Snowflake, Inc. Class A 336,850 37,876 (1) Tesla, Inc.(1) 162,740 108,699 Class A 110,700 25,381 Sprout Social, Inc.
[Show full text]
2015 AGM Minutes
OARC Annual General Meeting 3rd October 2015 - Minutes Date: Saturday 3rd October 2015 Location: Fairmont Queen Elizabeth, 900 Rene Levesque Blvd. W Montreal, Quebec H3B 4A5, Canada Chair: Ondrej Filip Secretary: Keith Mitchell Attendees Registered: 138 In person: 130, Remote: 7 Name Institution ISA, Saib CLEMENTS, Carl Afilias ROY, Jean Akamai Technologies LAWRENCE, David Akamai Technologies APRIL, Tim Akamai Technologies MILLER, Donavan Amazon ROBIN, Noah AOL DETWEILER, Valerie AOL HUSTON, Geoff APNIC BJØRN HANSEN, Ask Apple JEFFERS, David ARIN MIZELLE, Devon ARIN ROWLEY, Matt ARIN KE, Qiang BII KERR, Shane BII SILVA DAMAS, Joao Luis Bond Internet Systems JOHNSON, Aaron Charter Communications LIU, Charlie Charter Communications CONNELL, Isaiah Charter Communications SRIRAM, Ajay Charter Communications ZHANG, Tongfeng CIRA THOMPSON, Evan CIRA ZACK, Jacob CIRA LATOUR, Jacques CIRA STEWART, Jonathan CIRA SWAIN, Amanda CIRA MALENFANT, Eric CIRA CHANTIGNY, Rock CIRA BOOS, Roy Cisco Systems KWONG, David Cisco Systems VALSORDA, Filippo Cloudflare GUÐMUNDSSON, Ólafur CloudFlare ZHANG, Mingkai CNNIC XINYUE, Zhang CNNIC PAN, Lanlan CNNIC HAGOPIAN, Peter Comcast BARNITZ, John Comcast EBERSMAN, Paul Comcast HLAVACEK, Tomas CZ.NIC FILIP, Ondrej CZ.NIC SURÝ, Ondřej CZ.NIC PETRASCH, Christian DENIC BHABUTA, Denesh DNS-OARC KHEMLANI, Dalini DNS-OARC GRAVES, Susan DNS-OARC SOTOMAYOR, William DNS-OARC MITCHELL, Keith DNS-OARC DUARTE, Eduardo DNS.PT ROBERTS, Bruce DomainTools ALLEN, David Dyn GRAY, Robert Dyn COWIE, James Dyn HYNES, Liam Dyn KNIGHT, Dave
[Show full text]
Doctor of Pharmacy Fellowship Program
2021-2022 Doctor of Pharmacy Fellowship Program Accelerate your career with one of our 1-year fellowship programs Transformative Therapies Targeting Cancer Seagen Inc. is a global biotechnology company dedicated to discovering, developing, and commercializing transformative YEARS: In oncology for 23+ years cancer medicines to make a meaningful difference in people’s lives. SIZE: Largest biotechnology company ADCETRIS® (brentuximab vedotin) and PADCEV® (enfortumab vedotin-ejfv) use based in the Pacific Northwest the company’s industry-leading antibody-drug conjugate (ADC) technology. ADCETRIS is approved in certain CD30-expressing lymphomas, and PADCEV is EMPLOYEES: 2,200+ employees approved in certain metastatic urothelial cancers. TUKYSA® (tucatinib), a small mole- worldwide cule tyrosine kinase inhibitor, is approved in certain HER2-positive metastatic breast cancers. The company is headquartered in Seattle, Washington area, with loca- PASSION: Helping people with cancer tions in California, Switzerland and the European Union. Beyond our approved prod- ucts, the company has established a pipeline of novel targeted therapies at various stages of clinical testing. OUR MISSION OUR VALUES To discover, develop, and Passion for helping patients commercialize transformative cancer Revolutionizing therapies for people medicines to make a meaningful living with cancer difference in people’s lives. Integrity Honesty, respect and trust guide us Scientific excellence Premier science empowers our passion We have built a strong Diversity, teamwork, and corporate culture around our mutual respect mission and values. Seagen Shared dedication and diverse embodies an entrepreneurial perspectives drive successful spirit that advances collaborations breakthrough therapies, Innovation which is why we are the Entrepreneurial spirit advances leader in antibody-drug breakthrough therapies conjugate technology.
[Show full text]
Notice of 2019 Annual Meeting of Shareholders & Proxy Statement
Notice of 2019 Annual Meeting of Shareholders & Proxy Statement Wednesday, May 8, 2019, 10:00 a.m., Eastern Time Our PURPOSE To be a great company that creates exceptional long- term value for our customers, employees and shareholders by enhancing the health and well-being of pets, people and livestock. Out Guiding Principles achieve and sustain market leadership exceed the expectations of our customers empower and reward our employees innovate with intelligence cultivate entrepreneurial spirit contribute to our communities Our Achieve and sustain market GUIDING leadership PRINCIPLES Exceed the expectations of our customers Contribute Empower and to our reward our communities employees Cultivate Innovate entrepreneurial with spirit intelligence Jonathan W. Ayers President, Chief Executive Officer and Chairman of the Board of Directors March 25, 2019 Dear Fellow Shareholders, In 2018, IDEXX delivered another year of strong growth and financial performance, sustaining our track record of creating exceptional long-term value for our customers, employees and shareholders. We are inspired by the continued pursuit of our Purpose to enhance the health and well-being of pets, people and livestock. Our Purpose We achieved outstanding financial results in 2018, with 12% revenue growth over the prior year, driven by 12% organic revenue growth, operating margin expansion of To be a great company that creates 120 basis points and growth of diluted earnings per share (“EPS”) of 45% (or exceptional long-term value for our comparable constant currency EPS growth of 36%).1 We further extended our track customers, employees and record of long-term shareholder value-creation, as reflected in the 20% compound shareholders by enhancing the annual growth rate of our stock price over the past fifteen years, and our 19% annual health and well-being of pets, total shareholder return in 2018, which again outperformed the benchmark S&P people and livestock.
[Show full text]
FTIF - Franklin Global Growth Fund August 31, 2021
FTIF - Franklin Global Growth Fund August 31, 2021 FTIF - Franklin Global Growth August 31, 2021 Fund Portfolio Holdings The following portfolio data for the Franklin Templeton funds is made available to the public under our Portfolio Holdings Release Policy and is "as of" the date indicated. This portfolio data should not be relied upon as a complete listing of a fund's holdings (or of a fund's top holdings) as information on particular holdings may be withheld if it is in the fund's interest to do so. Additionally, foreign currency forwards are not included in the portfolio data. Instead, the net market value of all currency forward contracts is included in cash and other net assets of the fund. Further, portfolio holdings data of over-the-counter derivative investments such as Credit Default Swaps, Interest Rate Swaps or other Swap contracts list only the name of counterparty to the derivative contract, not the details of the derivative. Complete portfolio data can be found in the semi- and annual financial statements of the fund. Security Security Shares/ Market % of Coupon Maturity Identifier Name Positions Held Value TNA Rate Date G6095L109 APTIV PLC 70,000 $10,653,300 3.09% N/A N/A 045327103 ASPEN TECHNOLOGY INC 58,000 $7,511,000 2.18% N/A N/A BRIGHT HORIZONS FAMILY SOLUTIONS 109194100 49,000 $7,142,240 2.07% N/A N/A INC BROADRIDGE FINANCIAL SOLUTIONS 11133T103 46,000 $7,922,120 2.30% N/A N/A INC 124765108 CAE INC 360,000 $10,394,547 3.01% N/A N/A CHARLES RIVER LABORATORIES 159864107 27,000 $11,984,220 3.47% N/A N/A INTERNATIONAL
[Show full text]
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund a (Acc) USD This Fund Is Managed by Franklin Templeton International Services S.À R.L
31 May, 2021 Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund A (acc) USD This fund is managed by Franklin Templeton International Services S.à r.l. EFC Classification Equity Biotechnology Price +/- Date 52wk range 40.80 EUR 0.13 28/05/2021 36.82 50.31 Issuer Profile Administrator Franklin Templeton International Services S.à r.l. The Fund aims to achieve capital appreciation by investing principally in equity securities Address 8A, rue Albert Borschette 1246 of biotechnology companies and discovery research firms mainly located in the US. City Luxembourg Tel/Fax +352 46 66 67 212 Chart 5 year Website www.franklintempleton.lu General Information ISIN LU0109394709 Fund Type Capitalization 50 Quote Frequency daily Quote Currency USD 45 Currency USD Foundation Date 03/04/2000 40 Fund Manager Wendy Lam Legal Type Investment company according to Luxembourg law 35 UCITS Yes Financial Year End 30/06/2020 30 Fund size 1,786,183,025.88 USD Minimal Order 5,000.00 USD 25 Costs 20 Entry fee 5.75 % 2017 2018 2019 2020 2021 Infront Finance Exit fee 0.00 % 38 Days 200 Days Operation costs 1.50 % Ongoing charges 1.83 % Fund Returns 2016 2017 2018 2019 2020 2021 Returns -15.18 2.77 -12.34 36.10 16.74 -8.55 Category Average Category Ranking / / / / / / 40 20 s e u l a V 0 -20 2016 2017 2018 2019 2020 2021 Returns Category Average Fund Ratios (end previous month) Timing YTD 1 month 6 months 1 year 3 year 5 year Performance Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund A (acc) USD -4.26 % 0.75 % 10.52 % 23.66 % 12.07 % 10.78 % Volatility Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund A (acc) USD 15.27 % 22.74 % 21.59 % 31 May, 2021 Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund A (acc) USD This fund is managed by Franklin Templeton International Services S.à r.l.
[Show full text]